Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.
Comparison Of Tele-Rehabilitation Versus Conventional Rehabilitation To Improve Cognition Among Stroke Survivor.
This study aims to:
- Compare tele-rehabilitation and conventional rehabilitation for cognitive improvement after stroke.
- Evaluate changes in cognitive function using standardized assessment tools.
- Determine whether tele-rehabilitation is as effective as conventional therapy.
- Improve evidence-based rehabilitation strategies for stroke survivors.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Imran Amjad, PhD
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
Study Locations
-
-
Punjab Province
-
Islamabad, Punjab Province, Pakistan, 44000
- Recruiting
- Riphah International University
-
Contact:
- Imran Amjad, PhD
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults with age 50-80
- Diagnosed with ischemic or hemorrhagic stroke within subacute to chronic phase.
- Moca Score 10-25 score atleast
- For tele-rehab must accessible to a digital device.
Exclusion Criteria:
- History of neurodegenerative disorder e.g Alzheimer's Disease and Parkinson's Disease
- Severe Cognitive Impairment
- Lack of access to or inability to use a digital device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Tele-Rehabilitation Group
Participants will receive structured cognitive rehabilitation remotely through telecommunication platforms for 8 weeks.
Sessions will be conducted with comparable frequency and intensity to the control group.
|
Cognitive rehabilitation exercises delivered remotely using video-based sessions, targeting attention, memory, executive function, and processing speed.
Sessions will be conducted over 8 weeks.
|
|
Active Comparator: Conventional Rehabilitation Group
Participants will receive face-to-face cognitive rehabilitation sessions in a clinical setting for 8 weeks with similar frequency and duration as the tele-rehabilitation group.
|
In-person cognitive rehabilitation exercises targeting attention, memory, executive function, and processing speed delivered in a clinical setting for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Cognitive Function Measured by Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline
|
The Montreal Cognitive Assessment (MoCA) will be used to assess global cognitive function, including attention, memory, executive function, language, and visuospatial abilities.
Scores range from 0 to 30, with higher scores indicating better cognitive function.
|
Baseline
|
|
Change in Cognitive Function Measured by Montreal Cognitive Assessment (MoCA)
Time Frame: After 8 weeks
|
The Montreal Cognitive Assessment (MoCA) will be used to assess global cognitive function, including attention, memory, executive function, language, and visuospatial abilities.
Scores range from 0 to 30, with higher scores indicating better cognitive function.
|
After 8 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Executive Function Measured by stroop Test
Time Frame: Baseline
|
The Stroop test will be used to assess selective attention, cognitive flexibility, and inhibitory control.
Performance will be evaluated based on completion time and error rate.
|
Baseline
|
|
Change in Executive Function Measured by stroop Test
Time Frame: After 8 weeks
|
The Stroop test will be used to assess selective attention, cognitive flexibility, and inhibitory control.
Performance will be evaluated based on completion time and error rate.
|
After 8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Imran Amjad, Phd, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Mental Disorders
- Neurocognitive Disorders
- Cognition Disorders
- Stroke
- Cognitive Dysfunction
- Health Services Administration
- Delivery of Health Care
- Therapeutics
- Patient Care
- Health Services
- Health Care Facilities Workforce and Services
- Rehabilitation
- Aftercare
- Continuity of Patient Care
- Telemedicine
- Patient Care Management
- Telerehabilitation
Other Study ID Numbers
Other Study ID Numbers
- REC/02263 Imran Amjad
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.